During May 17-19 2010, Two Iran MOH officers accompanied by OSVAH Pharmaceutical Co. representatives inspected influenza facility. The MOH officers presented a report concerning the findings from three days' site inspection and documentation review. Tianyuan will establish a remediation plan and submit it to Iran MOH as soon as possible. The import permission will be issued as long as the remediation plan is approved. Two QC operators from OSVAH Pharmaceutical Co. learned the quality control techniques for bulk and final product of influenza vaccine in order to prepare for the testing of imported vaccine.
Generally speaking, only vaccine products imported from European and US manufacturers are popular in Iran market. Therefore, Tianyuan will be the first Chinese manufacturer to export its influenza vaccine to Iran once we get the permission successfully.